You started finasteride to protect your hair while on TRT. Your DHT was 353 pg/mL. Three months later, with finasteride daily and a lower testosterone dose, your DHT is 653 pg/mL.
That is not a typo. Your DHT nearly doubled while taking a drug designed to block it.
This is not rare. Across Reddit and TRT forums, men report the same confusing pattern: finasteride plus testosterone therapy sometimes produces higher DHT than testosterone alone. The drug that should protect your hair follicles appears to be making the problem worse.
The explanation is not that finasteride is fake. It is that most TRT discussions about DHT ignore enzyme isoforms, tissue-specific metabolism, and the difference between serum DHT and follicular DHT. If you do not understand those mechanisms, you will keep making protocol changes that cannot work.
What DHT Actually Does on TRT
Dihydrotestosterone (DHT) is not a side effect of testosterone. It is a metabolite produced when the enzyme 5-alpha-reductase converts testosterone into a more potent androgen.
DHT binds to androgen receptors with roughly 2 to 5 times the affinity of testosterone. In muscle tissue, this is beneficial for strength and recovery. In hair follicles genetically predisposed to androgenic alopecia, DHT miniaturizes follicles over time, producing the classic male pattern baldness progression.
The standard TRT narrative is simple: more testosterone means more DHT means more hair loss. Therefore, add finasteride to block 5-alpha-reductase and reduce DHT.
That model works for some men. For others, it fails completely because it ignores three critical variables.
The Three Variables Most Men Ignore
Variable 1: 5-alpha-reductase has three isoforms
There is not one 5-alpha-reductase enzyme. There are three:
- Type I: Primarily in skin, liver, and sebaceous glands
- Type II: Primarily in prostate, genital skin, and hair follicles
- Type III: Found in various tissues, less well-characterized
Finasteride primarily inhibits Type II. Dutasteride inhibits both Type I and Type II.
If your hair follicles express more Type I enzyme, finasteride will barely touch your follicular DHT production even while it lowers serum DHT measured in blood tests. The enzyme that matters for your hair is not the enzyme finasteride blocks efficiently.
Variable 2: Serum DHT is not follicular DHT
When you get a blood test for DHT, you are measuring circulating hormone in your bloodstream. That is not the same as DHT concentration inside hair follicle cells.
Local DHT production within the follicle can continue even when serum DHT drops. This is why some men see serum DHT fall on finasteride while hair loss accelerates. The drug reduced the wrong pool.
Variable 3: Higher testosterone doses can overwhelm finasteride capacity
Finasteride does not eliminate 5-alpha-reductase. It reduces enzyme activity by roughly 70% for Type II at standard 1mg doses.
If you increase testosterone substrate significantly, the remaining 30% of active enzyme can still produce more total DHT than you had at lower testosterone with 100% enzyme activity.
Mathematically:
- 100 units testosterone × 100% enzyme activity = 100 units DHT potential
- 200 units testosterone × 30% enzyme activity = 60 units DHT potential (finasteride working)
- 400 units testosterone × 30% enzyme activity = 120 units DHT potential (finasteride “failing”)
This is simplified, but the principle holds. At high enough testosterone doses, partial enzyme inhibition cannot keep pace with substrate availability.
The Reddit Case: What Actually Happened
A recent Reddit post captured this exact problem. A man with Kallmann syndrome on TRT provided clear data:
2025 protocol:
- 80mg testosterone per week (split into 2 injections)
- Topical minoxidil + finasteride 0.1% once daily
- DHT: 353 pg/mL
2026 protocol:
- 40mg testosterone per week (split into 2 injections)
- Oral finasteride 1mg daily
- DHT: 653 pg/mL
He reduced testosterone dose by 50% and switched from topical to oral finasteride. Both changes should theoretically lower DHT. Instead, DHT increased by 85%.
The most likely explanations:
Topical finasteride was providing local scalp inhibition that oral finasteride does not match at his specific follicle enzyme expression pattern.
Type I enzyme dominance in his follicles means oral finasteride (Type II selective) provides less hair protection than topical, even at higher systemic dose.
Absorption and metabolism variability between topical and oral routes created different effective concentrations at the target tissue.
This is not a failure of the drug. It is a mismatch between drug mechanism and individual enzyme expression.
Evidence Anchors for DHT Management
Use these as signal quality checks, not cherry-picked trivia.
5-alpha-reductase isoform distribution: Type I enzyme predominates in sebaceous glands and certain skin regions, while Type II dominates in prostate and genital tissue. Hair follicle expression varies by individual and scalp region (Russell & Wilson, Steroids, 1994).
Finasteride primarily inhibits Type II: At 1mg daily, finasteride reduces Type II activity by roughly 70% but has minimal effect on Type I (McConnell et al., Journal of Clinical Endocrinology and Metabolism, 1992).
Dutasteride inhibits both Type I and Type II: At 0.5mg daily, dutasteride reduces both isoforms more completely, producing greater total DHT suppression (Clark et al., Journal of Clinical Endocrinology and Metabolism, 2004).
Serum DHT does not perfectly predict scalp DHT: Tissue-specific metabolism means blood levels can diverge from follicle concentrations (Schwartz et al., Journal of Investigative Dermatology, 2012).
Testosterone dose affects DHT production linearly: Higher testosterone substrate generally produces more DHT, though individual conversion rates vary significantly (Swerdloff et al., Journal of Clinical Endocrinology and Metabolism, 2000).
Topical finasteride can achieve higher local concentrations: Direct scalp application may inhibit follicular 5-alpha-reductase more effectively than oral administration for some men (Mazzarella et al., Journal of Dermatological Treatment, 2021).
Three DHT Phenotypes on TRT
Most men fall into one of three patterns.
Phenotype 1: Type II dominant (finasteride responsive)
- Hair follicles express primarily Type II enzyme
- Oral finasteride reduces both serum and follicular DHT effectively
- Hair loss stabilizes or slows on standard 1mg dose
- Serum DHT drops 60-70% on labs
These men do well with standard protocols. They are not the ones posting confused Reddit threads.
Phenotype 2: Type I dominant (finasteride resistant)
- Hair follicles express more Type I enzyme
- Oral finasteride lowers serum DHT but not follicular DHT adequately
- Hair loss continues despite normal-appearing labs
- Serum DHT drops but hair does not stabilize
These men need either dutasteride (dual inhibition) or topical finasteride directly to the scalp. Oral finasteride alone cannot work well because it targets the wrong enzyme.
Phenotype 3: High substrate overwhelflow (dose-dependent)
- Very high testosterone doses produce enough substrate that even 70% enzyme inhibition leaves excess DHT production
- Lowering testosterone dose improves DHT control more than increasing finasteride
- Hair loss correlates more with testosterone dose than with finasteride dose
- Common in men on “blast” protocols or high TRT doses (200mg+ weekly)
These men need dose reduction first, enzyme inhibition second. Adding more finasteride to 250mg testosterone will not solve a substrate problem.
Practical DHT Management Protocol on TRT
This is the sequence that produces predictable outcomes.
Step 1: Establish baseline before adding finasteride
Before starting any 5-alpha-reductase inhibitor, get:
- Total testosterone, free testosterone, SHBG
- DHT (serum)
- Estradiol (sensitive assay)
- Document current hair loss pattern with photos
This tells you whether you are a high converter (DHT disproportionately elevated relative to testosterone) or normal converter.
Step 2: Choose finasteride formulation based on phenotype clues
If you have no prior finasteride response data:
- Start with topical finasteride 0.1% + minoxidil 5% once daily applied to affected scalp areas
- This provides local enzyme inhibition with lower systemic absorption
- Recheck serum DHT and photograph hair at 8-12 weeks
If topical is unavailable or causes scalp irritation:
- Use oral finasteride 1mg daily
- Accept that this primarily inhibits Type II enzyme
- If hair loss continues at 12 weeks with low serum DHT, you may be Type I dominant
If oral finasteride fails to stabilize hair despite low serum DHT:
- Discuss dutasteride 0.5mg daily with your clinician
- This inhibits both Type I and Type II isoforms
- More effective but also more side effect potential
Step 3: Adjust testosterone dose if DHT remains high
If serum DHT stays elevated despite finasteride:
- Reduce weekly testosterone dose by 20-30% if clinically appropriate
- Increase injection frequency (e.g., from weekly to twice weekly) to lower peak testosterone concentrations that drive conversion
- Recheck DHT at 6-8 weeks after dose change
Lower peaks often reduce DHT production more than the same total dose delivered in larger, less frequent injections.
Step 4: Add non-pharmaceutical interventions
These do not replace finasteride but can support hair preservation:
- Minoxidil 5% topical twice daily (if not already in combination product)
- Ketoconazole 2% shampoo 2-3 times weekly to reduce scalp inflammation
- Microneedling 1-1.5mm depth once weekly to stimulate follicle blood flow
- Ensure adequate zinc, vitamin D, and iron status (deficiencies worsen hair loss independent of DHT)
Step 5: Monitor and iterate every 12 weeks
At each checkpoint:
- Photograph hair from consistent angles and lighting
- Check serum DHT, testosterone, estradiol
- Assess side effects (libido changes, mood, cognitive function)
- Decide: continue, switch formulation, adjust dose, or add intervention
Do not change more than one variable per 8-12 week cycle or you lose attribution.
Non-Finasteride Options for Hair Preservation on TRT
If you cannot tolerate 5-alpha-reductase inhibitors or they do not work for your phenotype, alternatives exist.
Topical minoxidil alone
- Does not affect DHT at all
- Works through different mechanism (potassium channel opening, blood flow, follicle cell proliferation)
- Less effective than combination with finasteride but better than nothing
- Requires consistent twice-daily application
Ketoconazole shampoo
- Has mild anti-androgenic effects on scalp
- Reduces local inflammation that accelerates hair loss
- Not sufficient as standalone treatment for significant hair loss
Low-level laser therapy (LLLT)
- FDA-cleared devices for androgenic alopecia
- Mechanism: improved cellular energy production and blood flow
- Modest evidence but low risk profile
- Requires consistent use (typically 3x weekly for 15-25 minutes)
PRP (platelet-rich plasma) injections
- Involves drawing blood, concentrating platelets, injecting into scalp
- Mixed evidence, expensive, requires multiple sessions
- May help some men who do not respond to topical treatments
Hair transplant
- Does not address ongoing hair loss mechanism
- Moves DHT-resistant follicles from back of scalp to balding areas
- Best combined with medical therapy to prevent further loss
- Significant cost and recovery time
When DHT Is Necessary for TRT Efficacy
Here is the uncomfortable truth: DHT is not just a hair loss villain.
DHT contributes to:
- Libido and sexual function
- Strength and muscle maintenance
- Mood and cognitive function
- Androgen receptor activation (especially important for men with receptor sensitivity issues)
Aggressively suppressing DHT can produce side effects that some men find unacceptable:
- Reduced libido
- Erectile dysfunction
- Brain fog or reduced mental clarity
- Depressed mood
- Reduced gym performance
If finasteride or dutasteride produces these effects, you have a tradeoff decision:
- Accept some hair loss to preserve sexual and cognitive function
- Accept reduced libido and mental clarity to preserve hair
- Seek middle ground with lower enzyme inhibition dose or topical-only application
There is no correct answer. There is only the answer you can live with.
The 16-Week Implementation Sequence
This protocol assumes you are on stable TRT and want to address hair loss without crashing DHT systemically.
Weeks 0-2: Baseline
- Photograph hair from front, top, and crown
- Check total testosterone, free testosterone, DHT, estradiol
- Start minoxidil 5% twice daily if not already using
- Begin ketoconazole 2% shampoo 2-3x weekly
Weeks 2-8: Add topical finasteride
- Add topical finasteride 0.1% once daily (or combination min+fin product)
- Apply to affected areas only
- Continue minoxidil and ketoconazole
- Track any side effects daily
Week 8: First checkpoint
- Recheck DHT, testosterone, estradiol
- Photograph hair again
- Assess side effects and subjective hair shedding
If DHT is lower and hair is stable: continue current protocol
If DHT is lower but hair is still shedding: consider Type I dominance, discuss dutasteride with clinician
If DHT is unchanged or higher: reduce testosterone dose by 20% or increase injection frequency, then recheck at week 12
Weeks 8-16: Iterate
- Make only one protocol change based on week 8 data
- Continue photography and symptom tracking
- Recheck labs at week 16
This sequence gives you data to determine whether you are responding to finasteride, whether you need dutasteride, or whether dose adjustment is the primary lever.
Common Mistakes That Keep Men Stuck
Starting oral finasteride without understanding isoform differences and assuming serum DHT equals follicular DHT
Adding finasteride while simultaneously increasing testosterone dose and wondering why DHT does not fall
Using finasteride alone without minoxidil when combination therapy produces better hair outcomes
Quitting finasteride after 4 weeks because hair shedding increased (temporary shed is common and does not mean treatment is failing)
Ignoring side effects because you are afraid of losing hair (sexual and cognitive side effects are real and should prompt dose or formulation adjustment)
Treating DHT as purely negative and not recognizing its role in libido, strength, and mental function
Bottom Line
DHT can paradoxically increase on TRT with finasteride because the drug inhibits only one of three enzyme isoforms, serum DHT does not reflect follicular DHT, and high testosterone doses can overwhelm partial enzyme inhibition.
The men who succeed at hair preservation on TRT are not the ones who blindly add finasteride. They are the ones who:
- establish baseline DHT before starting treatment
- choose formulation (topical vs oral vs dutasteride) based on response data
- adjust testosterone dose when substrate overload is the driver
- add supporting interventions like minoxidil and ketoconazole
- accept that some DHT may be necessary for quality of life
If your DHT went up on finasteride, you did not fail. Your protocol failed to match your individual enzyme expression pattern. Fix the mechanism, not the dose.
Medical disclaimer: This article is educational and does not constitute medical advice. Finasteride, dutasteride, and testosterone therapy require clinician oversight. Side effects can include sexual dysfunction, mood changes, and teratogenicity in pregnant partners. Discuss all interventions with a qualified healthcare provider.